Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) regularly issues news and updates that shed light on its role as the world’s largest diversified manufacturer of professional dental products and technologies. Company press releases cover topics such as strategic partnerships, leadership changes, financial results and portfolio decisions, giving investors and dental professionals insight into how the business is evolving.
Recent news has highlighted Dentsply Sirona’s focus on connected dentistry and technology-enabled solutions. The company has announced expanded and renewed distribution partnerships in the United States that provide access to its dental technology portfolio, including systems and imaging solutions referenced in those agreements. These announcements emphasize integrated ecosystems that connect devices, software and services from scanning through design and manufacturing workflows.
News items also address corporate strategy and performance, including quarterly financial results and the introduction of a Return-to-Growth action plan. In these updates, Dentsply Sirona outlines priorities such as putting customers at the center, strengthening the U.S. business, and evolving operations to support innovation and training. Leadership appointments in commercial, finance and regional roles are frequently reported, reflecting the company’s efforts to align its organization with these priorities.
Other press releases describe decisions about the Wellspect Healthcare business, dividend declarations, participation in investor conferences and the conclusion of an SEC Division of Enforcement investigation without enforcement action. Together, these news items provide a detailed view of how Dentsply Sirona manages its portfolio, governance and capital allocation. Readers interested in XRAY can use this news feed to follow developments in connected dentistry, strategic partnerships, governance actions and financial communications from the company.
Dentsply Sirona (Nasdaq: XRAY) announced an enhanced U.S. distribution agreement with Atlanta Dental Supply effective August 1, 2026. The deal adds Dentsply Sirona’s connected technology portfolio — including CEREC, intraoral scanning, and digital imaging — to Atlanta Dental’s regional offering across the Southeast.
The expanded partnership aims to broaden access to digital dentistry via a well‑established, employee‑owned regional distributor with local service infrastructure and deep relationships with independent practices.
Dentsply Sirona (NASDAQ:XRAY) launched Smart View - Detect, the first FDA-cleared AI-enabled diagnostic aid for detecting teeth with periapical radiolucencies (PARLs) in CBCT scans, also CE approved in Europe. The company reports an internal multi-reader study showing ~46% relative increase in tooth-level PARL detection sensitivity versus unaided review. Available via DS Core for compatible Orthophos S, Orthophos SL, and Axeos systems; supports 5×5 to 17×11 fields of view. The feature is accessible for new and historical CBCT scans and will be available May 12, 2026, requiring a DS Core Standard or Advanced subscription.
Wellspect HealthCare (NASDAQ:XRAY) launched the Surity™ Male External Catheter in the U.S. on April 30, 2026, expanding its Surity™ continence portfolio already including a female catheter and an upcoming Surity™ Urinary Management System.
The device is non‑invasive, suitable for up to 24 hours wear, features a see‑through design and slim profile, and is available now for home purchase at www.surity.care; institutional availability is described as coming soon.
Dentsply Sirona (Nasdaq: XRAY) will host a first quarter 2026 results conference call and live webcast on Tuesday, May 5, 2026 at 4:30 p.m. ET. Financial earnings materials and the live webcast link will be posted in the Investors section of the company website prior to the call.
A replay of the webcast will be available on the Investors website after the call.
Dentsply Sirona and Siemens Healthineers (NYSE: XRAY) announced FDA clearance of the MAGNETOM Free.Max Dental Edition, the first dental-dedicated MRI, following a clinical trial validating its use across endodontics, periodontics, TMJ, extraction, and orthodontics.
The trial highlighted non-ionizing imaging, dental-specific field of view, under 20-minute average workflow, soft-tissue contrast that differentiates active inflammation and assesses tooth pulp vitality, and positioning relative to nerves. Training and demonstrations planned April 2026 and at ADEA March 21–24, 2026 in Montréal.
Dentsply Sirona (Nasdaq: XRAY) will present at the Leerink Partners Global Healthcare Conference on March 10, 2026 at 10:00 a.m. EST.
Investors can listen via a live audio webcast and access a replay through the Investors section of the company's website at https://investor.dentsplysirona.com.
Dentsply Sirona (Nasdaq: XRAY) reported Q4 2025 net sales of $961M (+6.2% vs. Q4 2024; constant currency +2.5%) and Q4 adjusted EPS of $0.27. GAAP results included $144M goodwill and intangible impairments, producing a Q4 net loss of ($146M) and diluted loss per share of ($0.74).
Full‑year 2025 net sales were $3.68B (down 3.0%); FY adjusted EPS was $1.60. The company announced a restructuring with ~$55–65M charges, ~$120M annualized savings, elimination of the quarterly dividend, and FY 2026 guidance of $3.5B–$3.6B sales and adjusted EPS $1.40–$1.50.
Dentsply Sirona (Nasdaq: XRAY) announced the appointments of James D. Forbes and Brian P. McKeon to its Board of Directors, effective February 27, 2026. Forbes brings 30 years of healthcare investment banking experience and will join the Compensation & Human Capital Committee. McKeon brings 25 years of CFO experience and will join the Audit and Finance Committee and Science and Technology Committee. The appointments aim to strengthen strategic, financial and governance capabilities to support the company’s Return-to-Growth action plan. In connection with board refreshment, Willie Deese intends to retire and will not stand for re-election after 15 years of service.
Dentsply Sirona (NASDAQ:XRAY) and Burkhart Dental Supply expanded their distribution partnership effective April 1, 2026, with Burkhart adding Dentsply Sirona’s full dental technology portfolio to its existing preventive and restorative offerings.
This includes CEREC systems, Primescan and Primescan 2 scanners, Axeos and Orthophos imaging, and aims to simplify purchasing and local support for dental practices.
Dentsply Sirona (Nasdaq: XRAY) will host a conference call and live webcast on Thursday, February 26, 2026 at 4:30 p.m. EST to review fourth quarter and full year 2025 financial results. A press release and a presentation with summary financial information will be posted on the company’s Investors website prior to the call.
The live webcast and a replay will be available at https://investor.dentsplysirona.com, and registered participants may join the call via the provided registration link.